Newsroom | 35236 results

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2024. Recent Business Highlights Soft Tissue Ablation Announced positive preliminary results from its first-in-human feasibility study using Nanosecond Pulsed Field Ablation technology for the t...

DUBLIN--(BUSINESS WIRE)--The "Pediatric Interventional Cardiology Market Report by Device Type, Procedure, End Use, Country and Company Analysis 2025 to 2033" report has been added to ResearchAndMarkets.com's offering. The Pediatric Interventional Cardiology market is poised for substantial growth, with projections estimating an increase from US$ 2.42 billion in 2024 to US$ 4.34 billion by 2033. This remarkable growth, registering a CAGR of 6.68% from 2025 to 2033, is driven by advancements in...

DUBLIN--(BUSINESS WIRE)--The "Spinal Fusion Device Market by Product Type, Surgery Type, End-Users, Region and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. The latest insights in the medical device industry indicate a robust growth trajectory for the spinal fusion device market, which is set to expand from US$ 7.88 billion in 2024 to reach a projected market size of US$ 11.23 billion by the year 2033. The compounded annual growth rate is predicted to b...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Voom Medical Devices, Inc., a leader in minimally invasive orthopedic solutions, is unveiling the new single-use sterile Revcon™ Screw System at the American College of Foot and Ankle Surgeons (ACFAS) annual meeting in Phoenix, AZ from March 26-29, 2025. The commercial launch of the system is slated for May 2025 and will include the highly anticipated debut of the MIBS CoPilot shift + targeting guide. Minimally invasive bunion surgery (MIBS) is rapidly becomin...

AACHEN, Alemania--(BUSINESS WIRE)--Protembis, empresa privada emergente dedicada a dispositivos médicos cardiovasculares, ha anunciado hoy la creación de un Consejo Científico Asesor (SAB) que proporcionará asesoramiento objetivo y contribuirá a los planes estratégicos de la empresa. En concreto, el CCC aportará orientación estratégica científica y clínica, asesorará sobre y oportunidades emergentes y tendencias, y proporcionará asesoramiento experto sobre asuntos científicos y clínicos. El Con...

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Mercy Health Center, a leading healthcare clinic based in Georgia, has recently decided to adopt eClinicalWorks solutions. The practice’s transition to the innovative eClinicalWorks V12, the first multidimensional and AI-powered EHR, introduces a unified healthcare solution to meet its unique needs while significantly transforming practice operations, enhancing patient care, and facilita...

DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The In Vitro Diagnostics Market was valued at USD 94.7 billion in 2024, and is expected to reach USD 141.9 billion by 2029, rising at a CAGR of 8.40%. This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current...

BALTIMORE--(BUSINESS WIRE)--Pantheon Vision, a preclinical-stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, today announced entering a collaboration agreement with manufacturer Eyedeal Medical. Under the terms of the agreement, the companies will work to advance the production and commercialization of Pantheon Vision’s bioengineered corneal implant. “Pantheon Vision has assembled a world-leading ophthalmic design team whose groundbreaking mi...

SAN JOSE, Calif.--(BUSINESS WIRE)--Shape Memory Medical Inc., innovator of shape memory polymer for endovascular applications, today announced that its proprietary platform has been used to treat its 3,000th patient—a significant milestone in the company’s commercialization and clinical strategy. The patient was enrolled in the company’s AAA-SHAPE Global Randomized Controlled Pivotal Trial, which has now surpassed 25% enrollment. This achievement reflects strong clinical adoption and represents...

DUBLIN--(BUSINESS WIRE)--The "Liposuction Surgery Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Liposuction Surgery Devices market is expected to reach US$ 5.24 billion by 2033 from US$ 1.90 billion in 2024, with a CAGR of 11.91% from 2025 to 2033 The growing demand for body shaping, improvements in minimally invasive technologies, and growing awareness of cosmetic procedures are all contribu...